Sintx Technologies Management

Management criteria checks 3/4

Sintx Technologies' CEO is B. Bal, appointed in Oct 2014, has a tenure of 9.5 years. total yearly compensation is $536.95K, comprised of 76.9% salary and 23.1% bonuses, including company stock and options. directly owns 0% of the company’s shares, worth $5.45. The average tenure of the management team and the board of directors is 8.9 years and 9.9 years respectively.

Key information

B. Bal

Chief executive officer

US$537.0k

Total compensation

CEO salary percentage	76.9%
CEO tenure	9.5yrs
CEO ownership	0.0001%
Management average tenure	8.9yrs
Board average tenure	9.9yrs

Recent management updates

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Nov 29

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Dec 09

Recent updates

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Nov 29

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Dec 09

SINTX Technologies jumps 25%, gets order for aerospace components

Oct 11

SINTX Technologies stock gains 8% premarket on $1.1M grant awarded by US Dept of Energy

Sep 27

SINTX Technologies acquires Technology Assessment and Transfer

Jul 06

SINTX Technologies joins Russell Microcap Index

Jun 09

CEO Compensation Analysis

How has B. Bal's remuneration changed compared to Sintx Technologies's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	US$537k	US$413k	-US$8m
Sep 30 2023	n/a	n/a	-US$14m
Jun 30 2023	n/a	n/a	-US$14m
Mar 31 2023	n/a	n/a	-US$14m
Dec 31 2022	US$512k	US$400k	-US$16m
Sep 30 2022	n/a	n/a	-US$10m
Jun 30 2022	n/a	n/a	-US$10m
Mar 31 2022	n/a	n/a	-US$10m
Dec 31 2021	US$483k	US$400k	-US$9m
Sep 30 2021	n/a	n/a	-US$9m
Jun 30 2021	n/a	n/a	-US$9m
Mar 31 2021	n/a	n/a	-US$11m
Dec 31 2020	US$487k	US$415k	-US$17m
Sep 30 2020	n/a	n/a	-US$16m
Jun 30 2020	n/a	n/a	-US$15m
Mar 31 2020	n/a	n/a	-US$14m
Dec 31 2019	US$401k	US$400k	-US$7m
Sep 30 2019	n/a	n/a	-US$8m
Jun 30 2019	n/a	n/a	-US$15m
Mar 31 2019	n/a	n/a	-US$22m
Dec 31 2018	US$412k	US$400k	-US$24m
Sep 30 2018	n/a	n/a	-US$24m
Jun 30 2018	n/a	n/a	-US$17m
Mar 31 2018	n/a	n/a	-US$9m
Dec 31 2017	US$482k	US$400k	-US$6m

Compensation vs Market: B.'s total compensation ($USD536.95K) is about average for companies of similar size in the US market ($USD670.12K).

Compensation vs Earnings: B.'s compensation has increased whilst the company is unprofitable.

CEO

B. Bal (61 yo)

9.5yrs

Tenure

US$536,951

Compensation

Dr. B. Sonny Bal, M.D. J.D. MBA, PhD, has been the Chief Executive Officer and President of Sintx Technologies, Inc. (formerly known as Amedica Corporation) since October 2014 and its Chairman since August...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
B. Bal	CEO, President	9.5yrs	US$536.95k	0.00011% $ 5.5
David O'Brien	Executive VP & COO	8.9yrs	US$483.60k	0.00053% $ 26.3
Michael Marcroft	Vice President of Sales & Marketing	1.3yrs	no data	no data
Gina Moss	Director of Operations	no data	no data	no data

8.9yrs

Average Tenure

Experienced Management: SINT's management team is seasoned and experienced (8.9 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
B. Bal	CEO, President	12.2yrs	US$536.95k	0.00011% $ 5.5
David Truetzel	Independent Director	13.6yrs	US$124.21k	0% $ 0
Erik Stookey	Independent Director	9.5yrs	US$43.43k	0% $ 0
Jeffrey White	Independent Director	10.3yrs	US$43.43k	no data
Mark Froimson	Independent Director	5.2yrs	US$43.18k	0% $ 0
Giuseppe Pezzotti	Member of Scientific Advisory Board	8.6yrs	no data	no data

9.9yrs

Average Tenure

62yo

Average Age

Experienced Board: SINT's board of directors are considered experienced (9.9 years average tenure).

Sintx Technologies Management

Management criteria checks 3/4

Key information

Recent management updates

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Sintx Technologies, Inc., Annual General Meeting, Dec 05, 2023

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Insufficient new directors

Sintx Technologies, Inc., Annual General Meeting, Dec 15, 2022

Insufficient new directors

Recent updates

Sintx Technologies Receives New Notification Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

Sintx Technologies, Inc. has filed a Follow-on Equity Offering.

Full year 2023 earnings: EPS misses analyst expectations

Sintx Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $1.030519 million.

Consensus revenue estimates increase by 17%

Sintx Technologies, Inc. Provides Estimated Revenue for the Fourth Quarter and Full Year Ended December 31, 2023

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Sintx Technologies, Inc., Annual General Meeting, Dec 05, 2023

SINTX Technologies Receives a Notice from Nasdaq Listing Qualifications Department of the Nasdaq Stock Market

Sintx Technologies, Inc. Receives Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

New major risk - Revenue and earnings growth

No longer forecast to breakeven

Second quarter 2023 earnings released: US$0.61 loss per share (vs US$10.16 loss in 2Q 2022)

Consensus EPS estimates fall by 16%

Consensus EPS estimates upgraded to US$2.53 loss

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 78% to US$23.00

Price target increased by 80% to US$200

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 70% to US$200

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $12.04 million.

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $12.04 million.

Sintx Technologies, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2022

Consensus forecasts updated

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Sintx Technologies Receives Notice from the Listing Qualifications Staff of Nasdaq

Consensus revenue estimates increase by 32%

Insufficient new directors

Sintx Technologies, Inc., Annual General Meeting, Dec 15, 2022

Price target increased to US$2.50

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $4.7 million.

SINTX Technologies jumps 25%, gets order for aerospace components

Sintx Technologies, Inc. Announces New Antibacterial Biomedical Patents and Expansion of Intellectual Property Portfolio

National Institutes of Health Announces Grant to Sintx Technologies for Development of 3D Printed Antimicrobial Trauma Device

SINTX Technologies stock gains 8% premarket on $1.1M grant awarded by US Dept of Energy

Oxford Performance Materials and SINTX Technologies Collaboration Yields Major Breakthrough in Orthopedic & Dental Coatings

No longer forecast to breakeven

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Sintx Technologies, Inc. (NasdaqCM:SINT) acquired Technology Assessment And Transfer, Inc. for 0.76 million.

SINTX Technologies acquires Technology Assessment and Transfer

Consensus forecasts updated

Consensus forecasts updated

Price target decreased to US$2.13

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Insufficient new directors

Full year 2021 earnings: EPS and revenues miss analyst expectations

No longer forecast to breakeven

Insufficient new directors

SINTX Technologies, Inc. Announces New Results on the Development of Manufacturing Technologies to Produce Fabrics Impregnated with SINTX Silicon Nitride, and the Antipathogenic Testing of These Fabrics

SINTX Technologies Receives A Notice from Nasdaq Listing Qualifications Department of the Nasdaq Stock Market

No longer forecast to breakeven

Price target decreased to US$3.00

Third quarter 2021 earnings released: US$0.095 loss per share (vs US$0.11 loss in 3Q 2020)

Consensus forecasts updated

Consensus revenue estimates fall to US$1.38m

Price target decreased to US$4.13

Consensus forecasts updated

Sintx Technologies, Inc. Announces the Sale of First Silicon Nitride Antipathogenic Powder to O2TODAY

SINTX Technologies joins Russell Microcap Index

Consensus revenue estimates fall to US$1.10m

First quarter 2021 earnings released: US$0.11 loss per share (vs US$1.35 loss in 1Q 2020)

SINTX Technologies Announces New Product Brand, FleX SN, For Antipathogenic and Biomedical Applications

SINTX Technologies Files Multiple New U.S. and International Patent Applications

Full year 2020 earnings released: US$1.01 loss per share (vs US$4.82 loss in FY 2019)

Sintx Technologies, Inc. Announces the Fabric Technology Shown to Inactivate Upon contact SARS-CoV-2, the Virus Causing the Covid-19 Pandemic

SINTX Technologies, Inc. Submits Master Access File to FDA for Silicon Nitride-Polymer Composite Material

O2TODAY and SINTX Technologies Enter Commercialization Agreement to Fight COVID-19